Found: 37
Select item for more details and to access through your institution.
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 3, p. 1105, doi. 10.1007/s10072-022-06498-7
- By:
- Publication type:
- Article
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 526, doi. 10.3390/ph16040526
- By:
- Publication type:
- Article
Quality of Life and Psychological Impact in Patients with Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 6, p. 1298, doi. 10.3390/jcm10061298
- By:
- Publication type:
- Article
Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2170, doi. 10.3390/jcm9072170
- By:
- Publication type:
- Article
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3561, doi. 10.2147/CCID.S416149
- By:
- Publication type:
- Article
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical Practice.
- Published in:
- Dermatology (10188665), 2014, v. 229, n. 4, p. 324, doi. 10.1159/000365077
- By:
- Publication type:
- Article
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1443, doi. 10.1007/s13555-024-01185-1
- By:
- Publication type:
- Article
Dupilumab‐associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report.
- Published in:
- Skin Health & Disease, 2024, v. 4, n. 3, p. 1, doi. 10.1002/ski2.354
- By:
- Publication type:
- Article
Successful long‐term guselkumab treatment of severe plaque psoriasis in patients with class III obesity: A case series.
- Published in:
- Skin Health & Disease, 2024, v. 4, n. 1, p. 1, doi. 10.1002/ski2.289
- By:
- Publication type:
- Article
Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5175, doi. 10.3390/jcm13175175
- By:
- Publication type:
- Article
Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 1876, doi. 10.3390/jcm13071876
- By:
- Publication type:
- Article
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 878, doi. 10.3390/jcm13030878
- By:
- Publication type:
- Article
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3545, doi. 10.3390/jcm12103545
- By:
- Publication type:
- Article
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2631, doi. 10.3390/jcm11092631
- By:
- Publication type:
- Article
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 2, p. 397, doi. 10.1007/s10067-017-3953-6
- By:
- Publication type:
- Article
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases.
- Published in:
- Case Reports in Dermatology, 2013, v. 5, n. 3, p. 254, doi. 10.1159/000348645
- By:
- Publication type:
- Article
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 10, p. 1, doi. 10.2340/00015555-3816
- By:
- Publication type:
- Article
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Linear psoriasis following the typical distribution of the sciatic nerve.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.
- Published in:
- Molecular Diagnosis & Therapy, 2018, v. 22, n. 6, p. 717, doi. 10.1007/s40291-018-0354-8
- By:
- Publication type:
- Article
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 5, p. 467, doi. 10.1007/s40291-017-0274-z
- By:
- Publication type:
- Article
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 3, p. 295, doi. 10.1007/s40291-017-0261-4
- By:
- Publication type:
- Article
Photo-recall cutaneous reaction to gemcitabine.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Tildrakizumab in moderate‐to‐severe plaque psoriasis: A multicenter, retrospective, real‐life study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15488
- By:
- Publication type:
- Article
Successful treatment of psoriatic crumbly nails with ustekinumab.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 3, p. N.PAG, doi. 10.1111/dth.12914
- By:
- Publication type:
- Article
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 3, p. N.PAG, doi. 10.1111/dth.12899
- By:
- Publication type:
- Article
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 2527, doi. 10.2147/dddt.s136986
- By:
- Publication type:
- Article
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 10, p. e852, doi. 10.1111/jdv.19929
- By:
- Publication type:
- Article
Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. 1461, doi. 10.1111/jdv.20175
- By:
- Publication type:
- Article
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1017, doi. 10.1111/jdv.18913
- By:
- Publication type:
- Article
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 6, p. 578, doi. 10.1111/1346-8138.15293
- By:
- Publication type:
- Article
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO<sub>2</sub> ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1813, doi. 10.1111/all.14767
- By:
- Publication type:
- Article
HLA‐C*06:02 allele can influence clinical efficacy of certolizumab pegol?
- Published in:
- Health Science Reports, 2021, v. 4, n. 2, p. 1, doi. 10.1002/hsr2.234
- By:
- Publication type:
- Article